ClinicalTrials.Veeva

Menu

Diode Laser Versus Topical Corticosteroids in Management of Oral Ulcers in Behcet's Disease (BD)

Cairo University (CU) logo

Cairo University (CU)

Status

Unknown

Conditions

Autoimmune
Behcet Syndrome

Treatments

Radiation: Diode laser 980nm&100 mWatt
Drug: Triamcinolone Acetonide

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Laser therapy is increasingly showing promising results in dental field including oral ulcers.This trial will assess the usefulness of Diode Laser compared to corticosteroid on oral ulcers of patients diagnosed with Behcet's disease.

Full description

The enrolled patients will be divided randomly into two groups.one group will receive Diode Laser (power:100 milli Watt,wavelength:980 mmm, delivery system:biostimulation probe) and other group will receive topical corticosteroids(Kenacort A Orabase: triamcinolone acetonide 0.1% 5 gram adhesive paste - Dermaphor) four times daily.

Enrollment

38 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients diagnosed with Behcet's Disease according to International Criteria for BD.
  • patients with active oral ulcers.
  • patients free from any visible oral lesions other than the oral ulcers of BD.
  • patients who agreed to take the supplied interventions.
  • patients who will agree to participate in the study.
  • patients who will accept to sign the informed consent.

Exclusion criteria

  • patients not physically able to participate in survey or clinical oral examination.
  • patients with organ or life-threatening disease.
  • patients with history of a severe or chronic medical condition including tuberculosis, hepatitis and human immunodeficiency virus.
  • patients under immunosuppressive drugs.
  • patients with organ transplantation.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

38 participants in 2 patient groups

Triamcinolone acetonide
Active Comparator group
Description:
Triamcinolone acetonide 0.1% 5 gm adhesive paste 4 times / day for 1 month.
Treatment:
Drug: Triamcinolone Acetonide
Diode laser
Experimental group
Description:
Diode laser 980 nm \& 100mWatt.
Treatment:
Radiation: Diode laser 980nm&100 mWatt

Trial contacts and locations

0

Loading...

Central trial contact

Clair Sobhy Nagieb, MSC; Zaki S.Zaki, MSC

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems